Daniel de Boer
Chief Executive Officer bij PROQR THERAPEUTICS N.V.
Vermogen: 2 M $ op 31-03-2024
Profiel
Daniel Anton de Boer is the founder of ProQR Therapeutics NV, PC Basic B.V., and Running It.
He held the position of Chief Executive Officer at each of these companies.
Additionally, he is also the founder of Amylon Therapeutics BV.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PROQR THERAPEUTICS N.V.
0.87% | 31-12-2023 | 705 309 ( 0.87% ) | 2 M $ | 31-03-2024 |
Actieve functies van Daniel de Boer
| Bedrijven | Functie | Begin |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Chief Executive Officer | 21-02-2012 |
Eerdere bekende functies van Daniel de Boer
| Bedrijven | Functie | Einde |
|---|---|---|
| Running It | Chief Executive Officer | 01-09-2011 |
| PC Basic B.V. | Chief Executive Officer | 01-02-2008 |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Founder | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| PC Basic B.V. | |
| Running It | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
